Skip to content
value.today

Bright Minds Biosciences Inc.

DRUG
$750 Mmarket cap on Aug 1, 2026+9275.0% since Jan 2024
Compare
World rank
#10,714
Revenue
—
For year ending September-2024
Net income
$-2 M
SEC filing
Employees
—

Bright Minds Biosciences Inc. in brief

Bright Minds Biosciences Inc. is a listed company in the Biotechnology industry, based in Chicago, Illinois, USA. Its market value was $750 M on 1 August 2026, which makes it the 10,714th largest listed company in the world and the 2,244th largest in the USA on this site. Its shares trade under the symbol DRUG (Nasdaq).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

About Bright Minds Biosciences Inc.

Additional information related us is available on SEDAR+ at www.sedarplus.ca and on our website at https://brightmindsbio.com/. We do not incorporate the contents of our website or of www.sedarplus.ca into this Annual Report. Information on our website does not constitute part of this Annual Report. In addition, the SEC maintains an internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC which can be viewed as www.sec.gov.

We are a biotechnology company dedicated to developing therapeutics to improve the lives of patients with severe and life-altering diseases, which was incorporated on May 31, 2019 under the laws of British Columbia, Canada.

From the company's annual report filed with the US SEC: read the report

Bright Minds Biosciences Inc. timeline

1 events, 2020
  1. 2020
  2. •
    · approximate
    First filing with the US SEC
    The company's first electronic filing in SEC EDGAR.

Events of Bright Minds Biosciences Inc. from SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$203 M$406 M$609 M$812 M2023202420252026

World rank over time

▲ up 19,878 places since 2022
2022-12-25: #30437#30,43720222023-07-30: #30450#30,45020232024-01-05: #31493#31,49320242026-03-08: #5660#5,66020262026-08-01: #10559#10,5592026

Rank in USA: #5,472 (Dec 2022) · #5,293 (Jul 2023) · #4,557 (Jan 2024) · #1,011 (Mar 2026) · #2,275 (Aug 2026)

Key ratios

market cap and latest results
P/E ratio
n/m (loss)
Price / sales
—
Price / book
182.9×
Free cash flow yield
—
Net margin
—
Operating margin
—
Return on equity
-50.2%
Liabilities / assets
9.3%

Financial history

USD · fiscal years · source: SEC filings
RevenueNet income
Fiscal year ending Sep 2020: revenue —, net income $-0M—FY20Fiscal year ending Sep 2021: revenue —, net income $-7M—FY21Fiscal year ending Sep 2022: revenue —, net income $-12M—FY22Fiscal year ending Sep 2023: revenue —, net income $-5M—FY23Fiscal year ending Sep 2024: revenue —, net income $-2M—FY24
Fiscal year endingRevenueGrowthOperating incomeNet incomeNet margin
Sep 2024———$-2M—
Sep 2023———$-5M—
Sep 2022———$-12M—
Sep 2021———$-7M—
Sep 2020———$-0M—

Cash flow, debt and per share

Fiscal year endingOperating cash flowCapital spendingFree cash flowEPS (diluted)Dividend / share
Sep 2024$-1M——$-0.48—
Sep 2023$-5M——$-1.47—
Sep 2022$-11M——$-4.74—
Sep 2021$-6M——$-3.81—
Sep 2020$-0M——$-0.10—

SEC filings

Official filings of Bright Minds Biosciences Inc. with the US Securities and Exchange Commission.

Annual results

Revenue
—
Operating income
—
Net income
$-2 M

For year ending September-2024 · source: SEC filing

Balance sheet

Total assets
$5 M
Total liabilities
$0 M
Total equity
$4 M

As of September-2024

Top 100 institutional investors in Bright Minds Biosciences Inc.#

As of Sep 30, 2026
110 institutions held 9.0 M shares (about 87.8% of the shares outstanding) on Sep 30, 2026. The ten largest hold 55.6%. Source: SEC Form 13F filings, filed through Nov 17, 2026. Change is since the previous quarter.This quarter is still being filed: about 99% of the institutions that reported last quarter have filed so far. Institutions that have not filed yet are missing from the list, not sellers; the list is brought up to date every day.
The 25 largest institutional investors in Bright Minds Biosciences Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
1Janus Henderson Group Ltd.1,349,107—13.18%$67 MNov 16, 2026
2Cormorant Asset Management, LP800,000-100,000 (-11.11%)7.81%$40 MNov 16, 2026
3BlackRock, Inc.651,794-34,390 (-5.01%)6.37%$32 MNov 13, 2026
4Vestal Point Capital, LP545,0000 (0.00%)5.32%$27 MNov 16, 2026
5Braidwell LP483,8220 (0.00%)4.73%$24 MNov 16, 2026
6Driehaus Capital Management LLC445,221+11,844 (+2.73%)4.35%$22 MNov 16, 2026
7Vivo Capital, LLC417,879-139,293 (-25.00%)4.08%$21 MNov 13, 2026
8Point72 Asset Management, L.P.372,481+45,065 (+13.76%)3.64%$19 MNov 16, 2026
9Adage Capital Partners GP, L.L.C.324,800-10,200 (-3.04%)3.17%$16 MNov 16, 2026
10Balyasny Asset Management L.P.304,561-40,492 (-11.74%)2.98%$15 MNov 16, 2026
11Ra Capital Management, L.P.265,0000 (0.00%)2.59%$13 MNov 16, 2026
12Deerfield Management Company, L.P.236,295-46,705 (-16.50%)2.31%$12 MNov 16, 2026
13Wellington Management Group LLP221,361+50,046 (+29.21%)2.16%$11 MNov 16, 2026
14MPM Bioimpact LLC195,669-6,445 (-3.19%)1.91%$10 MNov 16, 2026
15Parkman Healthcare Partners LLC148,227-56,826 (-27.71%)1.45%$7 MNov 16, 2026
16Goldman Sachs Group Inc135,089+1,400 (+1.05%)1.32%$7 MNov 16, 2026
17Eventide Asset Management, LLC130,0130 (0.00%)1.27%$6 MNov 13, 2026
18State Street Corp122,150-28 (-0.02%)1.19%$6 MNov 12, 2026
19Great Point Partners LLC109,6030 (0.00%)1.07%$5 MNov 16, 2026
20Geode Capital Management, LLC104,059-87 (-0.08%)1.02%$5 MNov 6, 2026
21B Group, Inc.95,000+27,500 (+40.74%)0.93%$5 MNov 16, 2026
22Acuta Capital Partners, LLC93,152+407 (+0.44%)0.91%$5 MNov 16, 2026
23Ikarian Capital, LLC88,9510 (0.00%)0.87%$4 MNov 16, 2026
24Millennium Management LLC88,640+21,900 (+32.81%)0.87%$4 MNov 16, 2026
25Morgan Stanley87,809+69,210 (+372.12%)0.86%$4 MNov 13, 2026
Show all 100: investors 26 to 100
Institutional investors 26 to 100 in Bright Minds Biosciences Inc.
#InstitutionShares heldChange (shares)% heldValueFiled
26Orbimed Advisors LLC81,000-12,000 (-12.90%)0.79%$4 MNov 16, 2026
27Sio Capital Management, LLC75,152+1,200 (+1.62%)0.73%$4 MNov 16, 2026
28Ameriprise Financial Inc57,840+19,938 (+52.60%)0.56%$3 MNov 16, 2026
29FMR LLC56,476+48,625 (+619.35%)0.55%$3 MNov 10, 2026
30Citadel Advisors LLC54,116-12,417 (-18.66%)0.53%$3 MNov 16, 2026
31Vanguard Portfolio Management LLC49,395-30,665 (-38.30%)0.48%$2 MNov 13, 2026
32Superstring Capital Management LP48,045+17,589 (+57.75%)0.47%$2 MNov 16, 2026
33Woodline Partners LP45,6680 (0.00%)0.45%$2 MNov 16, 2026
34Trexquant Investment LP41,852-28,763 (-40.73%)0.41%$2 MNov 16, 2026
35Schonfeld Strategic Advisors LLC41,710-24,567 (-37.07%)0.41%$2 MNov 16, 2026
36AdvisorShares Investments LLC39,822+15,548 (+64.05%)0.39%$2 MNov 9, 2026
37Northern Trust Corp39,796-2,670 (-6.29%)0.39%$2 MNov 16, 2026
38Artia Global Partners LP38,4070 (0.00%)0.38%$2 MNov 16, 2026
39Los Angeles Capital Management LLC35,375-372 (-1.04%)0.35%$2 MNov 12, 2026
40ADAR1 Capital Management, LLC32,300+2,000 (+6.60%)0.32%$2 MNov 16, 2026
41KVP Capital Advisors, LP31,8130 (0.00%)0.31%$2 MNov 16, 2026
42Walleye Capital LLC28,729-37,377 (-56.54%)0.28%$1 MNov 13, 2026
43Boothbay Fund Management, LLC21,979-5,891 (-21.14%)0.21%$1 MNov 16, 2026
44D. E. Shaw & Co., Inc.20,790New0.20%$1 MNov 16, 2026
45Quadrature Capital Ltd19,989New0.20%$1 MNov 13, 2026
46Jane Street Group, LLC19,156+12,756 (+199.31%)0.19%$1 MNov 12, 2026
47Platinum Investment Management LTD19,1270 (0.00%)0.19%$1 MNov 16, 2026
48HRT Financial LP19,019New0.19%$1 MNov 13, 2026
49Charles Schwab Investment Management Inc17,190-842 (-4.67%)0.17%$1 MNov 16, 2026
50Quantinno Capital Management LP16,300New0.16%$1 MNov 13, 2026
51Nuveen, LLC16,192-697 (-4.13%)0.16%$1 MNov 10, 2026
52Birchview Capital, LP15,400New0.15%$1 MNov 13, 2026
53Exome Asset Management LLC14,715+4,605 (+45.55%)0.14%$1 MNov 16, 2026
54Bank of New York Mellon Corp14,511-391 (-2.62%)0.14%$1 MNov 5, 2026
55Bank Of America Corp /de/13,942-13,024 (-48.30%)0.14%$1 MNov 16, 2026
56Engineers Gate Manager LP11,140+5,728 (+105.84%)0.11%$1 MNov 16, 2026
57Rhumbline Advisers9,001+268 (+3.07%)0.09%$0 MNov 10, 2026
58Tudor Investment Corp Et Al8,241-50 (-0.60%)0.08%$0 MNov 16, 2026
59DNB Asset Management As7,653+2,831 (+58.71%)0.07%$0 MNov 12, 2026
60Jpmorgan Chase & Co7,487+2,709 (+56.70%)0.07%$0 MNov 12, 2026
61UBS Group AG7,286-8,250 (-53.10%)0.07%$0 MNov 10, 2026
62Deutsche Bank AG\6,973-835 (-10.69%)0.07%$0 MNov 6, 2026
63Public Employees Retirement System Of Ohio6,930New0.07%$0 MNov 16, 2026
64LPL Financial LLC6,8950 (0.00%)0.07%$0 MNov 6, 2026
65American Century Companies Inc6,593New0.06%$0 MNov 12, 2026
66Vanguard Fiduciary Trust Co6,504-497 (-7.10%)0.06%$0 MNov 13, 2026
67Seven Fleet Capital Management LP6,3950 (0.00%)0.06%$0 MNov 16, 2026
68Price T Rowe Associates Inc /MD/6,1670 (0.00%)0.06%$0 MNov 16, 2026
69State Board Of Administration Of Florida Retirement System6,0910 (0.00%)0.06%$0 MNov 13, 2026
70ExodusPoint Capital Management, LP5,488New0.05%$0 MNov 16, 2026
71Aquatic Capital Management LLC4,950-15,881 (-76.24%)0.05%$0 MNov 16, 2026
72Alliancebernstein L.P.4,810-870 (-15.32%)0.05%$0 MNov 16, 2026
73MetLife Investment Management, LLC4,5110 (0.00%)0.04%$0 MNov 16, 2026
74MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.3,392-20 (-0.59%)0.03%$0 MNov 16, 2026
75Tower Research Capital LLC (TRC)3,091+2,080 (+205.74%)0.03%$0 MNov 16, 2026
76Barclays PLC2,940-316 (-9.71%)0.03%$0 MNov 6, 2026
77New York State Common Retirement Fund2,6000 (0.00%)0.03%$0 MNov 17, 2026
78Wells Fargo & Company/mn2,150-4,611 (-68.20%)0.02%$0 MNov 16, 2026
79Russell Investments Group, Ltd.2,144-409 (-16.02%)0.02%$0 MNov 6, 2026
80Police & Firemen's Retirement System of New Jersey2,0360 (0.00%)0.02%$0 MNov 9, 2026
81BNP Paribas Financial Markets1,839+605 (+49.03%)0.02%$0 MNov 12, 2026
82Natixis1,791New0.02%$0 MNov 6, 2026
83Royal Bank Of Canada1,473+340 (+30.01%)0.01%$0 MNov 16, 2026
84Strs Ohio900-2,400 (-72.73%)0.01%$0 MOct 30, 2026
85Legal & General Group Plc7180 (0.00%)0.01%$0 MNov 16, 2026
86Ameritas Investment Partners, Inc.6720 (0.00%)0.01%$0 MNov 13, 2026
87China Universal Asset Management Co., Ltd.500-100 (-16.67%)0.00%$0 MOct 28, 2026
88Citigroup Inc429-3,183 (-88.12%)0.00%$0 MNov 4, 2026
89Osaic Holdings, Inc.294+214 (+267.50%)0.00%$0 MNov 12, 2026
90Sterling Capital Management LLC243+217 (+834.62%)0.00%$0 MOct 22, 2026
91Allworth Financial LP155+107 (+222.92%)0.00%$0 MNov 17, 2026
92Arax Advisory Partners100+89 (+809.09%)0.00%$0 MNov 12, 2026
93California State Teachers Retirement System980 (0.00%)0.00%$0 MNov 13, 2026
94Rydar Equities, Inc.80New0.00%$0 MOct 13, 2026
95Farther Finance Advisors, LLC47New0.00%$0 MOct 8, 2026
96GAMMA Investing LLC46+26 (+130.00%)0.00%$0 MOct 8, 2026
97Vanguard Global Advisers, LLC32-3,838 (-99.17%)0.00%$0 MNov 13, 2026
98Pinnacle Wealth Planning Services, Inc.27-111 (-80.43%)0.00%$0 MOct 27, 2026
99Caitong International Asset Management Co., Ltd21-1,180 (-98.25%)0.00%$0 MOct 29, 2026
100TD Waterhouse Canada Inc.200 (0.00%)0.00%$0 MOct 16, 2026

All 110 institutional investors, with who bought and sold →

Mutual funds holding Bright Minds Biosciences Inc.#

74 funds hold shares worth $74 M (about 9.8% of the company). Since their previous reports 52 added shares and 9 sold, buying $12 M net.
Mutual funds holding Bright Minds Biosciences Inc.
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 iShares Russell 2000 ETFBlackRock Fund Advisors194,417$14 M1.9%0.02%+15%Jun 30, 2026
🇺🇸 Eventide Healthcare & Life Sciences FundEventide Asset Management, LLC130,013$9 M1.3%0.51%no changeJun 30, 2026
🇺🇸 BlackRock Health Sciences Opportunities PortfolioBlackRock Advisors, LLC95,655$8 M0.93%0.14%no changeMay 29, 2026
🇺🇸 Fidelity Small Cap Index FundFidelity Management & Research Company LLC81,231$6 M0.79%0.02%+18%Jul 31, 2026
🇺🇸 iShares Russell 2000 Growth ETFBlackRock Fund Advisors69,591$5 M0.68%0.03%+22%Jun 30, 2026
🇺🇸 Vanguard Russell 2000 Index FundThe Vanguard Group, Inc.35,879$3 M0.35%0.02%+43%May 31, 2026
🇺🇸 Driehaus Micro Cap Growth FundDriehaus Capital Management LLC41,568$3 M0.41%0.49%−1.0%Jun 30, 2026
🇺🇸 Vanguard U.S. Momentum Factor ETFThe Vanguard Group, Inc.28,882$3 M0.28%0.14%+30%May 31, 2026
🇺🇸 BlackRock Health Sciences Term TrustBlackRock Advisors, LLC31,933$2 M0.31%0.21%no changeJun 30, 2026
🇺🇸 Adara Smaller Companies FundRBB Fund, Inc.20,238$2 M0.20%0.22%no changeMay 31, 2026
🇺🇸 iShares Micro-Cap ETFBlackRock Fund Advisors24,919$2 M0.24%0.12%+42%Jun 30, 2026
🇺🇸 Blackstone Alternative Multi-Strategy FundBlackstone Alternative Investment Advisors LLC22,267$2 M0.22%0.04%+31%Jun 30, 2026
🇺🇸 Goldman Sachs Small Cap Equity Insights FundGoldman Sachs Asset Management, L.P.18,815$1 M0.18%0.14%+328%Jul 31, 2026
🇺🇸 Schwab Small-Cap Index FundCharles Schwab Investment Management, Inc.18,032$1 M0.18%0.02%+18%Jul 31, 2026
🇺🇸 Master Small Cap Index SeriesBlackRock Advisors, LLC13,852$1 M0.14%0.02%+22%Jun 30, 2026
🇺🇸 Goldman Sachs Small Cap Growth Insights FundGoldman Sachs Asset Management, L.P.11,730$1 M0.11%0.26%+220%Jul 31, 2026
🇺🇸 Nuveen Small Cap Blend Index FundTeachers Advisors, LLC9,859$1 M0.10%0.02%+18%Jul 31, 2026
🇺🇸 Destinations Small-Mid Cap Equity FundBrinker Capital Investments, LLC7,015$1 M0.07%0.08%−7.8%May 31, 2026
🇺🇸 BlackRock Health Sciences TrustBlackRock Advisors, LLC8,368$1 M0.08%0.10%no changeJun 30, 2026
🇺🇸 EQ/2000 Managed Volatility PortfolioEquitable Investment Management Group, LLC8,241$1 M0.08%0.02%+14%Jun 30, 2026
🇺🇸 Vanguard Russell 2000 Growth Index FundThe Vanguard Group, Inc.6,507$1 M0.06%0.03%+41%May 31, 2026
🇺🇸 LVIP Franklin Templeton Multi-Factor SMID Cap Equity FundLincoln Financial Investments Corporation8,020$1 M0.08%0.05%newJun 30, 2026
🇺🇸 Fidelity Nasdaq Composite Index FundFidelity Management & Research Company LLC6,137$1 M0.06%<0.01%+15%May 31, 2026
🇺🇸 State Street SPDR S&P International Small Cap ETFSSGA Funds Management, Inc.7,531$1 M0.07%0.06%+1.1%Jun 30, 2026
🇺🇸 Fidelity Enhanced Small Cap Core ETFFidelity Management & Research Company LLC7,054$0 M0.07%<0.01%newJun 30, 2026
🇺🇸 Fidelity Small Cap Growth Index FundFidelity Management & Research Company LLC6,943$0 M0.07%0.03%+31%Jun 30, 2026
🇺🇸 Health Sciences PortfolioPacific Life Fund Advisors LLC5,663$0 M0.06%0.10%no changeJun 30, 2026
🇺🇸 LVIP State Street Small-Cap Index FundLincoln Financial Investments Corporation5,400$0 M0.05%0.02%+54%Jun 30, 2026
🇺🇸 SIMT Small Cap FundSEI Institutional Managed Trust5,400$0 M0.05%0.07%newJun 30, 2026
🇺🇸 Nuveen Equity Index FundTeachers Advisors, LLC5,025$0 M0.05%<0.01%newJul 31, 2026
🇺🇸 EQ/Small Company Index PortfolioEquitable Investment Management Group, LLC4,810$0 M0.05%0.02%+2432%Jun 30, 2026
🇺🇸 Goldman Sachs Variable Insurance Trust Small Cap Equity Insights FundGoldman Sachs Asset Management, L.P.4,402$0 M0.04%0.13%newJun 30, 2026
🇺🇸 NVIT GS Small Cap Equity Insights FundNATIONWIDE FUND ADVISORS4,059$0 M0.04%0.13%+115%Jun 30, 2026
🇺🇸 Small Cap Index FundNorthern Trust Investments, Inc.3,805$0 M0.04%0.02%+16%Jun 30, 2026
🇺🇸 Global X Russell 2000 ETFGlobal X Management Company LLC3,553$0 M0.03%0.02%+17%Jul 31, 2026
🇺🇸 Small Cap Index FundThe Variable Annuity Life Insurance Company2,886$0 M0.03%0.02%+36%May 31, 2026
🇺🇸 Goldman Sachs ActiveBeta U.S. Small Cap Equity ETFGoldman Sachs Asset Management, L.P.2,740$0 M0.03%0.02%newMay 31, 2026
🇺🇸 ATM Small Cap Managed Volatility PortfolioEquitable Investment Management Group, LLC2,528$0 M0.02%0.02%+18%Jun 30, 2026
🇺🇸 State Street Small/mid Cap Equity Index PortfolioSSGA Funds Management, Inc.2,400$0 M0.02%<0.01%no changeJun 30, 2026
🇺🇸 MetLife Russell 2000 Index PortfolioBrighthouse Investment Advisers, LLC2,270$0 M0.02%0.01%no changeJun 30, 2026
🇺🇸 Small-Cap Index PortfolioPacific Life Fund Advisors LLC2,235$0 M0.02%0.02%+23%Jun 30, 2026
🇺🇸 iShares Russell 3000 ETFBlackRock Fund Advisors1,977$0 M0.02%<0.01%−0.7%Jun 30, 2026
🇺🇸 Siit Extended Market Index FundSEI INVESTMENTS MANAGEMENT CORPORATION1,500$0 M0.01%0.01%+150%May 31, 2026
🇺🇸 Multi-Manager U.S. Small Cap Equity FundGoldman Sachs Asset Management, L.P.1,466$0 M0.01%0.04%—Apr 30, 2026
🇺🇸 1290 VT Micro Cap PortfolioEquitable Investment Management Group, LLC1,663$0 M0.02%0.05%+33%Jun 30, 2026
🇺🇸 NVIT Small Cap Index FundNATIONWIDE FUND ADVISORS1,651$0 M0.02%0.02%+21%Jun 30, 2026
🇺🇸 Small Cap Index TrustJohn Hancock Variable Trust Advisers LLC1,516$0 M0.01%0.02%+19%Jun 30, 2026
🇺🇸 AQR Small Cap Momentum Style FundAQR CAPITAL MANAGEMENT, LLC1,419$0 M0.01%0.06%—Mar 31, 2026
🇺🇸 Bridge Builder Small/Mid Cap Growth FundOLIVE STREET INVESTMENT ADVISERS LLC1,315$0 M0.01%<0.01%no changeJun 30, 2026
🇺🇸 iShares Russell Small/Mid-Cap Index FundBlackRock Advisors, LLC1,196$0 M0.01%<0.01%no changeJul 31, 2026
🇺🇸 DWS Small Cap Index VIPDWS Investment Management Americas, Inc.1,163$0 M0.01%0.02%+19%Jun 30, 2026
🇺🇸 T. Rowe Price Small-Cap Index FundT. Rowe Price Associates, Inc.1,131$0 M0.01%0.02%+42%Jun 30, 2026
🇺🇸 EQ/Morgan Stanley Small Cap Growth PortfolioEquitable Investment Management Group, LLC1,121$0 M0.01%0.02%+19%Jun 30, 2026
🇺🇸 BlackRock Small Cap Index V.I. FundBlackRock Advisors, LLC1,043$0 M0.01%0.02%+23%Jun 30, 2026
🇺🇸 Voya RussellTM Small Cap Index PortfolioVoya Investments, LLC911$0 M<0.01%0.02%+29%Jun 30, 2026
🇺🇸 SA Small Cap Index PortfolioSunAmerica Asset Management, LLC868$0 M<0.01%0.02%+69%Jul 31, 2026
🇺🇸 Vanguard Russell 3000 Index FundThe Vanguard Group, Inc.587$0 M<0.01%<0.01%+67%May 31, 2026
🇺🇸 Nationwide Small Cap Index FundNATIONWIDE FUND ADVISORS677$0 M<0.01%0.02%+23%Jul 31, 2026
🇺🇸 PD Small-Cap Growth Index PortfolioPacific Life Fund Advisors LLC675$0 M<0.01%0.03%+30%Jun 30, 2026
🇺🇸 CVT Russell 2000 Small Cap Index PortfolioCalvert Research and Management672$0 M<0.01%0.02%+43%Jun 30, 2026
🇺🇸 SmallCap Growth Fund IPrincipal Global Investors, LLC639$0 M<0.01%<0.01%+56%Jul 31, 2026
🇺🇸 Venerable Small Cap Index FundVenerable Investment Advisers, LLC588$0 M<0.01%0.02%+54%Jun 30, 2026
🇺🇸 Voya VACS Index Series SC PortfolioVoya Investments, LLC499$0 M<0.01%0.02%+21%Jun 30, 2026
🇺🇸 iShares Total U.S. Stock Market Index FundBlackRock Advisors, LLC462$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 ProShares Russell 2000 High Income ETFPROSHARE ADVISORS LLC328$0 M<0.01%0.02%+50%May 31, 2026
🇺🇸 Strategic Equity Allocation TrustJohn Hancock Variable Trust Advisers LLC329$0 M<0.01%<0.01%−33%Jun 30, 2026
🇺🇸 ProShares UltraPro Russell2000PROSHARE ADVISORS LLC261$0 M<0.01%<0.01%−16%May 31, 2026
🇺🇸 ProShares Ultra Russell2000PROSHARE ADVISORS LLC257$0 M<0.01%<0.01%−18%May 31, 2026
🇺🇸 EQ/Franklin Small Cap Value Managed Volatility PortfolioEquitable Investment Management Group, LLC229$0 M<0.01%<0.01%no changeJun 30, 2026
🇺🇸 Morgan Stanley Pathway Small-Mid Cap Equity ETFCONSULTING GROUP ADVISORY SERVICES LLC136$0 M<0.01%<0.01%−9.3%May 31, 2026
🇺🇸 State Street Total Return V.I.S. FundSSGA Funds Management, Inc.169$0 M<0.01%<0.01%+1.8%Jun 30, 2026
🇺🇸 Nationwide Fundamental All Cap Equity PortfolioNATIONWIDE FUND ADVISORS150$0 M<0.01%<0.01%no changeJul 31, 2026
🇺🇸 Total Stock Market Index TrustJohn Hancock Variable Trust Advisers LLC155$0 M<0.01%<0.01%+30%Jun 30, 2026
🇺🇸 Goldman Sachs Absolute Return Tracker FundGoldman Sachs Asset Management, L.P.39$0 M<0.01%<0.01%+56%Jun 30, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 74 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Insider trading at Bright Minds Biosciences Inc.#

Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.

Bought, 12 months
0
0 purchases, 0 insiders
Sold, 12 months
9.8 M
1 sale, 1 insider
Net, 12 months
-9.8 M
open market only
Insiders on file
2
since
$4.0 M-$9.8 M$0Oct 2024: bought $3.2 M (11 trades), sold $0 (0 trades)Oct 24Nov 2024: bought $4.0 M (1 trades), sold $0 (0 trades)NovApr 2026: bought $0 (0 trades), sold $9.8 M (1 trades)Apr
Bought (open market)Sold (open market)Hover a month for the totals
Bright Minds Biosciences Inc.: latest insider trades
TradedInsiderTradeSharesPriceValueOwned afterFiling
filed Cormorant Asset Management, LPFormer 10% OwnerSellindirect-109,33189.509.8 Mlocal950,000Form 4
filed Cormorant Asset Management, LP10% ownerBuyindirect+184,33121.704.0 Mlocal1.06 MForm 4
filed Cormorant Global Healthcare Master Fund, LP10% ownerBuyindirect+39,74323.22923 Klocal864,743Form 4
filed Cormorant Global Healthcare Master Fund, LP10% ownerBuyindirect+7,15024.03172 Klocal871,893Form 4
filed Cormorant Global Healthcare Master Fund, LP10% ownerBuyindirect+3,10725.2278 Klocal875,000Form 4
filed Cormorant Global Healthcare Master Fund, LP10% ownerBuyindirect+238,0974.5301.1 Mlocal690,506Form 4
filed Cormorant Global Healthcare Master Fund, LP10% ownerBuyindirect+63,1735.920374 Klocal753,679Form 4
filed Cormorant Global Healthcare Master Fund, LP10% ownerBuyindirect+33,3436.420214 Klocal787,022Form 4

Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals. This company files with the SEC as a foreign issuer; its insiders often report prices in the home currency, so amounts are as filed and not converted to dollars

Markets and events: Bright Minds Biosciences Inc.#

Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.

Short interest, 2026-10-30
801,241
7.91 days to cover
Shares sold short, last 24 reportsAll stocks →

Trading halts

  • 2026-11-02 12:25 UTC, code T3, resumed 13:00 UTC

Fails to deliver

  • : 280 shares at $56.69
  • : 850 shares at $54.02
  • : 78 shares at $50.44
  • : 297 shares at $50.71
  • : 2,775 shares at $51.36

Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables

Bright Minds Biosciences Inc. scorecard#

Passes 1 of the 7 checks that could be worked out. Fiscal year 2024; market cap of Aug 1, 2026.

  • Valuationnot known
    • –P/E below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
    • –Price to book below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
    • –Price to sales below its peers' medianThe market cap dates from 2026-08-01, more than 60 days ago.
    • –Free cash flow yield above 5%The market cap dates from 2026-08-01, more than 60 days ago.
    • –Earnings yield above the 10-year Treasury yieldThe market cap dates from 2026-08-01, more than 60 days ago.
    • –The price assumes slower growth than the last three years'The market cap dates from 2026-08-01, more than 60 days ago.
  • Growth0 of 1
    • –Revenue grew in the newest yearRevenue of the year before is not on file.
    • –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
    • –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
    • ✗Earnings per share grew in the newest year-0.48 vs -1.47Diluted EPS -0.48 in fiscal 2024 against -1.47 the year before (report's currency).
    • –Net income higher than five years earlierNet income of five years earlier is not on file.
    • –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
  • Profitability0 of 3
    • ✗Profitable in the newest year-$2 MNet income -$2 M in fiscal 2024.
    • ✗Profitable in each of the last five years0 of 5Profitable in 0 of the five years to fiscal 2024.
    • –Operating margin above its peers' medianNo operating margin on file.
    • ✗Return on equity above 15%-45.7%-45.7% in fiscal 2024.
    • –Return on invested capital above 10%No return on invested capital on file.
    • –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
  • Financial health1 of 2
    • ✓Short-term assets cover short-term liabilities11.4×Current ratio 11.36 at the end of fiscal 2024.
    • –Debt below equityDebt or equity is not on file (or equity is negative).
    • –Net debt below three years of EBITDANet debt to EBITDA is not on file.
    • –Operating income covers interest five timesInterest expense is not on file.
    • ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2024.
    • –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
  • Shareholder returns0 of 1
    • –Pays a dividendDividends are not on file.
    • –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
    • –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
    • ✗Share count up no more than 2% in a year15.9%Diluted shares up 15.9% in fiscal 2024.
    • –Dividends and buybacks above 3% of the market valueThe market cap dates from 2026-08-01, more than 60 days ago.
    • –Free cash flow covers dividends and buybacksCash from operations or capital spending is not on file.

Worked out from the statements as filed (sec), the medians of Biotechnology, the 10-year Treasury yield of Nov 13, 2026 and the market cap (too old for the valuation checks, which need one at most 60 days old). A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work

Bright Minds Biosciences Inc.: financial statements#

Income statement, balance sheet and cash-flow statement as reported, newest period first.

Amounts in CAD thousands; per-share figures in CAD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).

Bright Minds Biosciences Inc.: statements by fiscal year
PeriodTrendFY 2024to Sep 30, 2024FY 2023to Sep 30, 2023FY 2022to Sep 30, 2022FY 2021to Sep 30, 2021FY 2020to Sep 30, 2020
Income statement
Research and development1,1805,00012,1816,314355
Selling and marketing421195528529.6
Interest and finance income3000——
Income tax00000
Net income including minority interests−2,802−7,372−14,965−8,651−480
Earnings per share, basic-0.65-1.98-6.06-4.82—
Earnings per share, diluted-0.65-1.98-6.06r-4.82r-0.13
Shares, weighted average (basic)4.33.72.5r1.8r3.6
Shares, weighted average (diluted)4.33.72.51.8—
Balance sheet
Cash and cash equivalents5,7206,74811,62819,760800
Current assets5,9876,81311,94820,038878
Right-of-use (leased) assets118661390—
Total assets6,1056,87912,08720,040880
Accounts payable4492071,405639151
Current liabilities5292811,472639—
Lease liabilities (non-current)400720—
Total liabilities5682811,544639151
Retained earnings−34,349−31,547−24,175−9,210−559
Total equity5,5366,59810,54319,402729
Total liabilities and equity6,1056,87912,08720,040880
Cash-flow statement
Depreciation and amortization73726.000
Share-based compensation8401,152875881161
Cash from operating activities−1,850−7,024−13,587−7,319−288
Shares issued———27,7451,008
Cash from financing activities8112,1905,19626,0561,008
Exchange-rate effect on cash12−452592240
Change in cash−1,040−4,835−8,39118,736720
Report20-F20-F20-F20-F20-F

r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies

Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.

Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2024. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative

Acquisitions and funding#

Private share sales · funding history

Private share sales of Bright Minds Biosciences Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Nov 2024$35 MPrivate placement after listing$10 to $50 million13equitySEC

Source: Annual reports and Form D notices filed with the SEC; Wikidata. Acquisitions are the businesses the company reports as acquired in its newest annual report, with the price paid. Funding rounds do not name their investors; the investors listed are those Wikidata records.

H-1B hiring at Bright Minds Biosciences Inc.#

1 labor condition applications certified in fiscal 2026 for 1 positions, at a median wage of $207 K a year.

Certified, FY2026
1
#1,915 among companies on value.today
Worker positions
1
Median wage offered
$207 K
a year, full-time
Applications filed
1
Bright Minds Biosciences Inc.: most frequent H-1B job titles in fiscal 2026
Job titlePositionsMedian wage offered
Chief Operations OfficerNatural Sciences Managers1$207 K

Where: Chicago, IL 1

Bright Minds Biosciences Inc.: labor condition applications by fiscal year
Fiscal yearCertifiedPositionsMedian wageFiled
FY202611$207 K1
FY202411$72 K1
FY202111$64 K1

Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Bright Minds Biosciences LLC and Bright Minds Biosciences LLC

Discuss Bright Minds Biosciences Inc.#

1 automatic updates and 0 member comments. Sign in to comment and react.

  • Mutual funds: 74 funds hold $74 millionautomatic update · Jul 31, 2026

    74 mutual funds in 1 country hold shares of Bright Minds Biosciences Inc. worth $74 million, about 9.8% of the company (funds' newest reports, up to 31 July 2026). Since their previous reports 52 funds added shares and 9 sold; on balance they bought $12 million. Share splits are not counted as trading.

How Bright Minds Biosciences Inc. compares in Biotechnology

  • Market cap$750 M · higher than 63% of 726
  • Price / book182.9× · lower than 1% of 534

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Bright Minds Biosciences Inc.🇺🇸$750 M———
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Aug 1, 2026
Annual results:
For year ending September-2024
Balance sheet:
As of September-2024
Profile updated:
Nov 20, 2026

Figures from Market data, SEC filing, value.today research, SEC annual report; financial statements from SEC filings.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Bright Minds Biosciences Inc.? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Bright Minds Biosciences Inc.'s ranking or a chart on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Bright Minds Biosciences Inc.? Suggest a correction